Answers are grounded in this paper and cite their sources.
This is the first report of secondary resistance to rifampin following MDT in a patient with prolonged, but irregular treatment. Repeated mouse foot-pad studies demonstrated resistance to dapsone after several years of monotherapy, and following subsequent MDT the studies demonstrated the development of resistance to rifampin.
No takes yet. Share an insight, caveat, or question.
Norman et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: